Literature DB >> 8095902

Salmeterol is a competitive antagonist at beta-adrenoceptors mediating inhibition of respiratory burst in guinea-pig eosinophils.

K F Rabe1, M A Giembycz, G Dent, R S Perkins, P Evans, P J Barnes.   

Abstract

The ability of the long-acting beta-adrenoceptor agonists eformoterol and salmeterol to inhibit leukotriene (LT) B4 (100 nM; approximately EC70)-induced hydrogen peroxide (H2O2) generation by guinea-pig peritoneal eosinophils was investigated and compared with salbutamol. Eformoterol and salbutamol produced a concentration-dependent inhibition of LTB4-induced H2O2 generation with pIC50 values of 6.22 and > 5.0 respectively. The inhibitory effect eformoterol was mediated through an interaction with beta-adrenoceptors for it was antagonised by propranolol with an affinity (7.21) that was independent of antagonist concentration (100 nM and 1 microM). In contrast, salmeterol (1 nM to 10 microM) failed to inhibit H2O2 generation at any concentration examined irrespective of the pre-incubation time (0, 0.25, 0.5, 1, 2, 15 or 30 min). Salmeterol did, however, competitively antagonise (slope of Schild plot = 0.91) the inhibition of H2O2 generation induced by eformoterol with a pA2 of 5.9. Possible explanations for the lack of inhibitory effect of salmeterol on LTB4-induced respiratory burst are advanced and critically discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8095902     DOI: 10.1016/0014-2999(93)90466-u

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

Review 1.  Salmeterol. A review of its pharmacological properties and clinical efficacy in the management of children with asthma.

Authors:  J C Adkins; D McTavish
Journal:  Drugs       Date:  1997-08       Impact factor: 9.546

Review 2.  Understanding how long-acting β2 -adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids in asthma - an update.

Authors:  Robert Newton; Mark A Giembycz
Journal:  Br J Pharmacol       Date:  2016-11-09       Impact factor: 8.739

3.  Effects of agents which elevate cyclic AMP on guinea-pig eosinophil homotypic aggregation.

Authors:  M M Teixeira; A G Rossi; M A Giembycz; P G Hellewell
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

4.  Inhibition by fenoterol of human eosinophil functions including beta2-adrenoceptor-independent actions.

Authors:  A Tachibana; M Kato; H Kimura; T Fujiu; M Suzuki; A Morikawa
Journal:  Clin Exp Immunol       Date:  2002-12       Impact factor: 4.330

5.  Effect of a single dose of salmeterol on the increase in airway eosinophils induced by allergen challenge in asthmatic subjects.

Authors:  F L Dente; L Bancalari; E Bacci; M L Bartoli; S Carnevali; S Cianchetti; A Di Franco; D Giannini; B Vagaggini; R Testi; P L Paggiaro
Journal:  Thorax       Date:  1999-07       Impact factor: 9.139

6.  Corticosteroid insensitivity is reversed by formoterol via phosphoinositide-3-kinase inhibition.

Authors:  C Rossios; Y To; G Osoata; M Ito; P J Barnes; K Ito
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

7.  The interaction between salmeterol and beta 2-adrenoceptor agonists with higher efficacy on guinea-pig trachea and human bronchus in vitro.

Authors:  B L Källström; J Sjöberg; B Waldeck
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

Review 8.  Potential mechanisms to explain how LABAs and PDE4 inhibitors enhance the clinical efficacy of glucocorticoids in inflammatory lung diseases.

Authors:  Mark A Giembycz; Robert Newton
Journal:  F1000Prime Rep       Date:  2015-02-03

Review 9.  Formoterol in the management of chronic obstructive pulmonary disease.

Authors:  Paschalis Steiropoulos; Argyris Tzouvelekis; Demosthenes Bouros
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.